Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population

Gene
Won Hee KimNam Keun Kim

Abstract

Recent studies have suggested that common genetic polymorphisms alter the processing of microRNA (miRNA) and may be associated with the development and progression of cancer. The association of miRNA polymorphisms with HCC survival was analyzed in 159 HCC patients and 201 controls by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The risk of HCC was significantly lower for the miR-499A>G, AG+GG in HCC patients (AOR=0.603, 95% CI=0.370-0.984) and hepatitis B virus (HBV)-related HCC patients (AOR=0.561, 95% CI 0.331-0.950). In addition, the risk of HCC was significantly lower for the miR-149C>T, CT and CT+CC in HCC patients (CT; AOR=0.542, 95% CI=0.332-0.886, CT+CC; AOR=0.536, 95% CI=0.335-0.858) and HBV-related HCC patients (CT: AOR=0.510, 95% CI 0.305-0.854, CT+CC: AOR=0.496, 95% CI 0.302-0.813). The miR-149C>T polymorphism was also associated with survival rate of HCC patients in OKUDA II stage. miR-149C>T and miR-499A>G were associated with HBV-related HCC. Further studies on larger populations will need to be conducted to confirm these results.

References

Sep 15, 2004·Genome Research·Antony RodriguezAllan Bradley
Sep 17, 2004·The EMBO Journal·Yoontae LeeV Narry Kim
Oct 28, 2005·The New England Journal of Medicine·Chang-Zheng Chen
Mar 17, 2006·The New England Journal of Medicine·Michael P Czech
Mar 25, 2006·Nature Reviews. Cancer·Aurora Esquela-Kerscher, Frank J Slack
Sep 23, 2006·Developmental Biology·Baohong ZhangTodd A Anderson
May 3, 2007·JAMA : the Journal of the American Medical Association·Scott A Waldman, Andre Terzic
Jan 29, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jinmai JiangThomas D Schmittgen
Jan 31, 2008·JAMA : the Journal of the American Medical Association·Aaron J SchetterCurtis C Harris
Apr 25, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yannick LadeiroJessica Zucman-Rossi
Jun 4, 2008·The Journal of Clinical Investigation·Zhibin HuHongbing Shen
Jul 24, 2008·International Journal of Cancer. Journal International Du Cancer·Wenxi LiJianren Gu
Dec 3, 2008·Biological Reviews of the Cambridge Philosophical Society·Niamh Lynam-LennonJohn V Reynolds
Dec 17, 2008·Journal of Hepatology·Lei ChenHong-Yang Wang
Dec 19, 2008·The New England Journal of Medicine·Frank J Slack, Joanne B Weidhaas
Jan 6, 2009·Journal of Cellular and Molecular Medicine·Laura GramantieriMassimo Negrini
Jan 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Krystian JazdzewskiAlbert de la Chapelle
Jan 30, 2009·Journal of Gastroenterology and Hepatology·Junming GuoYanjun Wang
Feb 28, 2009·Clinical Chemistry·Claudine L Bartels, Gregory J Tsongalis
Aug 28, 2009·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Tsutomu Masaki
Oct 9, 2009·The New England Journal of Medicine·Junfang JiXin Wei Wang
Oct 17, 2009·Digestive Diseases and Sciences·Sheng PengQinghong Cheng
Oct 31, 2009·International Journal of Cancer. Journal International Du Cancer·Zhaohui HuangXiang Du
Oct 31, 2009·International Journal of Cancer. Journal International Du Cancer·Somesh Baranwal, Suresh K Alahari
Jan 2, 2010·Journal of Cancer Research and Clinical Oncology·Hyun-Chul LeeSoo-Han Jun
Jul 14, 2010·Molecular Carcinogenesis·Ruey-Jen LinAlice L Yu
Nov 18, 2010·Carcinogenesis·William K K WuJoseph J Y Sung
Nov 19, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yan-Ru QinXin-Yuan Guan

❮ Previous
Next ❯

Citations

Feb 23, 2013·TheScientificWorldJournal·Jie SunHongchuan Jin
Sep 12, 2013·World Journal of Gastroenterology : WJG·Sharad KhareJamal A Ibdah
Jun 18, 2014·BMC Bioinformatics·Xiaohan Sun, Junying Zhang
Nov 22, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hongzhi SunWei Wang
Mar 13, 2014·Pediatric Research·Angela Gutierrez-CaminoAfrica Garcia-Orad
May 13, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Bing ZhouLong-Feng Zhao
Jul 31, 2014·Cell Biochemistry and Biophysics·Fangfeng LiuYongfeng Liu
Jul 22, 2014·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Asahiro Morishita, Tsutomu Masaki
Jan 1, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Yu-Xia HaoLong-Feng Zhao
Feb 18, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Ying-Jun LiKun Chen
Jun 4, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·You-Gai ZhangJia-Chen Shi
Mar 10, 2015·Clinics and Research in Hepatology and Gastroenterology·Song HeCheng Wei
Apr 14, 2016·Journal of Cancer Research and Therapeutics·Huiling SunShukui Wang
Mar 13, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ning CongJin-Long Song
Mar 19, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Zhengjun KangChaohui Gu
Aug 2, 2016·Clinics and Research in Hepatology and Gastroenterology·Wen Qun Xie, Xiao Fan Wang
Jul 13, 2018·Cell Proliferation·Yingru ZhiRui Wang
Oct 14, 2014·World Journal of Gastroenterology : WJG·Hong-Xia Fan, Hua Tang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis